Literature DB >> 12791858

Limitations of TaqMan PCR for detecting divergent viral pathogens illustrated by hepatitis A, B, C, and E viruses and human immunodeficiency virus.

Shea N Gardner1, Thomas A Kuczmarski, Elizabeth A Vitalis, Tom R Slezak.   

Abstract

Recent events illustrate the imperative to rapidly and accurately detect and identify pathogens during disease outbreaks, whether they are natural or engineered. Particularly for our primary goal of detecting bioterrorist releases, detection techniques must be both species-wide (capable of detecting all known strains of a given species) and species specific. Due to classification restrictions on the publication of data for species that may pose a bioterror threat, we illustrate the challenges of finding such assays using five nonthreat organisms that are nevertheless of public health concern: human immunodeficiency virus (HIV) and four species of hepatitis viruses. Fluorogenic probe-based PCR assays (TaqMan; Perkin-Elmer Corp., Applied Biosystems, Foster City, Calif.) may be sensitive, fast methods for the identification of species in which the genome is conserved among strains, such as hepatitis A virus. For species such as HIV, however, the strains are highly divergent. We use computational methods to show that nine TaqMan primer and probe sequences, or signatures, are needed to ensure that all strains will be detected, but this is an unfeasible number, considering the cost of TaqMan probes. Strains of hepatitis B, C, and E viruses show intermediate divergence, so that two to three TaqMan signatures are required to detect all strains of each virus. We conclude that for species such as hepatitis A virus with high levels of sequence conservation among strains, signatures can be found computationally for detection by the TaqMan assay, which is a sensitive, rapid, and cost-effective method. However, for species such as HIV with substantial genetic divergence among strains, the TaqMan assay becomes unfeasible and alternative detection methods may be required. We compare the TaqMan assay with some of the alternative nucleic acid-based detection techniques of microarray, chip, and bead technologies in terms of sensitivity, speed, and cost.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791858      PMCID: PMC156483          DOI: 10.1128/JCM.41.6.2417-2427.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Development of reverse transcription-PCR assays specific for detection of equine encephalitis viruses.

Authors:  B Linssen; R M Kinney; P Aguilar; K L Russell; D M Watts; O R Kaaden; M Pfeffer
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 2.  Flow cytometry: an 'old' tool for novel applications in medical genetics.

Authors:  N Wedemeyer; T Pötter
Journal:  Clin Genet       Date:  2001-07       Impact factor: 4.438

3.  Sequence-specific identification of 18 pathogenic microorganisms using microarray technology.

Authors:  W J Wilson; C L Strout; T Z DeSantis; J L Stilwell; A V Carrano; G L Andersen
Journal:  Mol Cell Probes       Date:  2002-04       Impact factor: 2.365

Review 4.  Virus 'quasispecies': making a mountain out of a molehill?

Authors:  D B Smith; J McAllister; C Casino; P Simmonds
Journal:  J Gen Virol       Date:  1997-07       Impact factor: 3.891

5.  Fluorescent microsphere-based readout technology for multiplexed human single nucleotide polymorphism analysis and bacterial identification.

Authors:  F Ye; M S Li; J D Taylor; Q Nguyen; H M Colton; W M Casey; M Wagner; M P Weiner; J Chen
Journal:  Hum Mutat       Date:  2001-04       Impact factor: 4.878

6.  Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR).

Authors:  K M Weinberger; E Wiedenmann; S Böhm; W Jilg
Journal:  J Virol Methods       Date:  2000-03       Impact factor: 2.014

7.  Highly sensitive Taqman PCR detection of Puumala hantavirus.

Authors:  D Garin; C Peyrefitte; J M Crance; A Le Faou; A Jouan; M Bouloy
Journal:  Microbes Infect       Date:  2001-07       Impact factor: 2.700

8.  Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system.

Authors:  T Morris; B Robertson; M Gallagher
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

9.  Molecular Detection of Diaporthe phaseolorum and Phomopsis longicolla from Soybean Seeds.

Authors:  A W Zhang; G L Hartman; B Curio-Penny; W L Pedersen; K B Becker
Journal:  Phytopathology       Date:  1999-09       Impact factor: 4.025

Review 10.  High density synthetic oligonucleotide arrays.

Authors:  R J Lipshutz; S P Fodor; T R Gingeras; D J Lockhart
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

View more
  24 in total

Review 1.  Current advances in dengue diagnosis.

Authors:  Pei-Yun Shu; Jyh-Hsiung Huang
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

2.  Electrical detection of single viruses.

Authors:  Fernando Patolsky; Gengfeng Zheng; Oliver Hayden; Melike Lakadamyali; Xiaowei Zhuang; Charles M Lieber
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

3.  Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes.

Authors:  Peilin Li; Theodore Ruel; Katsuya Fujimoto; Hiroyu Hatano; Steven Yukl; Leigh Anne Eller; Teri Liegler; Moses Kamya; Anne Gassasira; Grant Dorsey; Philip J Rosenthal; Diane V Havlir; Joseph K Wong
Journal:  J Virol Methods       Date:  2010-09-21       Impact factor: 2.014

4.  Sequencing needs for viral diagnostics.

Authors:  Shea N Gardner; Marisa W Lam; Nisha J Mulakken; Clinton L Torres; Jason R Smith; Tom R Slezak
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

5.  System to assess genome sequencing needs for viral protein diagnostics and therapeutics.

Authors:  Shea N Gardner; Thomas A Kuczmarski; Carol E Zhou; Marisa W Lam; Tom R Slezak
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

6.  Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT.

Authors:  Priscilla Swanson; Carmen de Mendoza; Yagnya Joshi; Alan Golden; Richard L Hodinka; Vincent Soriano; Sushil G Devare; John Hackett
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 7.  Advantages of peptide nucleic acids as diagnostic platforms for detection of nucleic acids in resource-limited settings.

Authors:  Ning Zhang; Daniel H Appella
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

8.  Real-time PCR assay for detection and quantification of hepatitis B virus genotypes A to G.

Authors:  Tania M Welzel; Wendell J Miley; Thomas L Parks; James J Goedert; Denise Whitby; Betty A Ortiz-Conde
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

9.  Bacterial and viral pathogens in live oysters: 2007 United States market survey.

Authors:  Angelo DePaola; Jessica L Jones; Jacquelina Woods; William Burkhardt; Kevin R Calci; Jeffrey A Krantz; John C Bowers; Kuppuswamy Kasturi; Robin H Byars; Emily Jacobs; Donna Williams-Hill; Khamphet Nabe
Journal:  Appl Environ Microbiol       Date:  2010-02-26       Impact factor: 4.792

10.  SYBR green-based real-time quantitative PCR assay for detection of West Nile Virus circumvents false-negative results due to strain variability.

Authors:  James F Papin; Wolfgang Vahrson; Dirk P Dittmer
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.